Early Switch to Mammalian Target of Rapamycin Inhibitors Is a Sustainable Treatment Approach in Renal Transplant Recipients: 7-Year Results

dc.date.accessioned	2020-10-21T06:44:47Z
dc.date.available	2020-10-21T06:44:47Z
dc.date.issued	2019
dc.date.issued	2019/04/15
dc.identifier.citation	Açıkgöz SB, Dheir H.,.Transplant Proc. 2019 May;51(4):1070-1073. doi: 10.1016/j.transproceed.2019.01.098. Epub 2019 Feb 8.
dc.identifier.uri	http://doi.org/10.1016/j.transproceed.2019.01.098
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71323
dc.description	PMID = 30981406
dc.relation.isversionof	10.1016/j.transproceed.2019.01.098
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Early Switch to Mammalian Target of Rapamycin Inhibitors Is a Sustainable Treatment Approach in Renal Transplant Recipients: 7-Year Results
dc.type	article
dc.relation.journal	Transplant Proc
dc.identifier.doi	10.1016/j.transproceed.2019.01.098
dc.contributor.author	Turunç V
dc.contributor.author	Açıkgöz SB
dc.contributor.author	Dheir H.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi